Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - glycopyrroniumbromid, neostigminmethylsulfat - injektionsvæske, opløsning - 0,5 + 2,5 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

zambon s.p.a. - colistimethatnatrium - pulver til infusionsvæske, opløsning - 1.000.000 ie

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm healthcare a/s - ipratropiumbromid, xylometazolinhydrochlorid - næsespray, opløsning - 0,6 mg/ml+0,5 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

teva b.v. - tiotropiumbromid - inhalationspulver, hård kapsel - 10 mikrogram

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

fresenius kabi ab - rocuroniumbromid - injektions-/infusionsvæske, opløsning - 10 mg/ml

Den Europæiske Union - dansk - EMA (European Medicines Agency)

chiesi farmaceutici s.p.a. - beclometasone dipropionate, formoterol fumarate dihydrat, glycopyrronium bromid - pulmonal sygdom, kronisk obstruktiv - medicin for obstruktiv sygdomme, - maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year. copdmaintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5. asthmamaintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - tiotropium bromid - inhalationspulver, hård kapsel - 18 mikrogram

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - tiotropium bromid - inhalationsvæske, opløsning - 2,5 mikrogram

Den Europæiske Union - dansk - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - teriparatid - osteoporosis; osteoporosis, postmenopausal - calciumhomeostase - teriparatide sun is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

stada arzneimittel ag - teriparatid - osteoporose - calciumhomeostase - movymia er indiceret hos voksne. behandling af osteoporose hos postmenopausale kvinder og hos mænd med øget risiko for brud. hos postmenopausale kvinder er der vist en signifikant reduktion i forekomsten af ​​vertebrale og ikke-vertebrale frakturer, men ikke hoftefrakturer.. behandling af osteoporose, der er forbundet med vedvarende systemisk glukokortikoid behandling, kvinder og mænd med øget risiko for fraktur.